Clinical Trials Directory

Trials / Completed

CompletedNCT00898170

Effect of Myoma Removal on Blood Pressure and Erythropoetin Level

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
28 (actual)
Sponsor
Shiraz University of Medical Sciences · Academic / Other
Sex
Female
Age
22 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The effect of myoma removal was studied on 28 patients with hypertension and myoma by holter monitoring and erythropoetin level check.

Detailed description

Background: Myoma is the most common gynecoid tumor and produces many vasoactive substances, which may be a cause for secondary hypertension. Early reports suggested the association of myoma and hypertension. We studied the effect of myoma removal on hypertension and erythropoietin level to evaluate this hypothesis. Patients \& Methods: In this single centered prospective cohort study, in twenty eight patients who were candidates for myomectomy due to myoma, 24 hour holter monitoring of blood pressure and serum erythropoietin were checked before and 6 weeks after hysterectomy.

Conditions

Interventions

TypeNameDescription
PROCEDUREmyoma removalsurgical removal of myoma by hysterectomy

Timeline

Start date
2008-05-01
Primary completion
2009-03-01
Completion
2009-03-01
First posted
2009-05-12
Last updated
2009-05-12

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT00898170. Inclusion in this directory is not an endorsement.